Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

How I treat von Willebrand disorders in older adults

Jacqueline N. Poston, Rebecca Kruse-Jarres

Blood (2024) 143 (3): 197–204.

https://doi.org/10.1182/blood.2022018534

Published: 2024

Journal Articles

Rituximab in the Treatment of Refractory Heparin Induced Thrombocytopenia

Akshee Batra, Rohit Singh, Aneesh Singal, Jacqueline N. Poston

Blood (2022) 140 (Supplement 1): 11339–11341.

https://doi.org/10.1182/blood-2022-170542

Published: 2022

Journal Articles

Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

Terry B. Gernsheimer, Siobhan P. Brown, Darrell J. Triulzi, Nigel S. Key, Nahed El Kassar, Heather Herren, Jacqueline N. Poston, Michael Boyiadzis, Brandi N. Reeves, Subodh Selukar, Monica B. Pagano, Scott Emerson, Susanne May

Blood (2022) 140 (11): 1254–1262.

https://doi.org/10.1182/blood.2022016308

Published: 2022

Includes: Supplemental data

Journal Articles

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

Jacqueline N. Poston, Kadhim Al-Banaa, Annette von Drygalski, Aric D. Parnes, Christopher E Walsh, James F Wu, Craig M. Kessler, Maissaa Janbain, Lynn M Malec, Rebecca Kruse-Jarres

Blood (2021) 138 (Supplement 1): 496.

https://doi.org/10.1182/blood-2021-148040

Published: 2021

Journal Articles

A Pilot Study of Weekly Brentuximab Vedotin in Patients with CD30+ Malignancies Resistant to Every 3 Week Brentuximab Vedotin

Jacqueline N. Poston, MD, Jonathan R. Fromm, MD PhD, Heather A. Rasmussen, BS, Andrei R. Shustov, MD, Edward N. Libby, III, MD, Stephen D. Smith, MD, Ted Gooley, PhD, Ajay K. Gopal, MD

Blood (2017) 130 (Supplement 1): 1528.

https://doi.org/10.1182/blood.V130.Suppl_1.1528.1528

Published: 2017

NARROW

How I treat von Willebrand disorders in older adults

Rituximab in the Treatment of Refractory Heparin Induced Thrombocytopenia

Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

A Pilot Study of Weekly Brentuximab Vedotin in Patients with CD30+ Malignancies Resistant to Every 3 Week Brentuximab Vedotin

Email alerts

ASH Publications

American Society of Hematology

How I treat von Willebrand disorders in older adults

Rituximab in the Treatment of Refractory Heparin Induced Thrombocytopenia

Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

A Pilot Study of Weekly Brentuximab Vedotin in Patients with CD30+ Malignancies Resistant to Every 3 Week Brentuximab Vedotin

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only